Abstract
Aims: To investigate the factors of postoperative malignant brain edema (MBE) in
patients with acute ischemic stroke (AIS) treated with endovascular treatment (EVT).
Background: MBE is a severe complication following EVT for AIS, and it is essential to identify
risk factors early. Peripheral arterial lactate (PAL) levels may serve as a potential predictive
marker for MBE.
Objective: To determine whether immediate postoperative PAL levels and the highest PAL level
within 24 hours of EVT are independently associated with MBE development in AIS patients.
Methods: We retrospectively analyzed patients with AIS who underwent EVT from October
2019 to October 2022. Arterial blood was collected every 8 h after EVT to measure PAL, and
record the immediate postoperative PAL and the highest PAL level within 24 h. Brain edema
was evaluated using brain computed tomography scans within 7 days of EVT.
Results: The study included 227 patients with a median age of 71 years, of whom 59.5% were
male and MBE developed in 25.6% of patients (58/227). Multivariate logistic regression analysis
showed that the immediate postoperative PAL (odds ratio, 1.809 [95% confidence interval (CI),
1.215-2.693]; p = 0.004) and the highest PAL level within 24 h of EVT (odds ratio, 2.259 [95%
CI, 1.407-3.629]; p = 0.001) were independently associated with MBE. The area under the curve
for predicting MBE based on the highest PAL level within 24 hours of EVT was 0.780 (95% CI,
0.711-0.849).
Conclusion: Early increase in PAL levels is an independent predictor of MBE after EVT in AIS patients.
[24]
Bhatti MS, Frostig RD. Astrocyte-neuron lactate shuttle plays a pivotal role in sensory-based neuroprotection in a rat model of permanent middle cerebral artery occlusion. Sci Rep 2023; 13(1): 12799.
[25]
Kang BS, Choi BY, Kho AR, Lee SH, Hong DK, Park MK, et al. Effects of pyruvate kinase M2 (PKM2) gene deletion on astrocyte-specific glycolysis and global cerebral ischemia-induced neuronal death. Antioxidants (Basel) 2023; 12(2)
[26]
Berthet C, Lei H, Thevenet J, Gruetter R, Magistretti PJ, Hirt L. Neuroprotective role of lactate after cerebral ischemia. J Cereb Blood Flow Metab 2009; 29(11): 1780-9.
[29]
Li F, Geng X, Ilagan R, Bai S, Chen Y, Ding Y. Exercise postconditioning reduces ischemic injury via suppression of cerebral gluconeogenesis in rats. Brain Behav 2023; 13(1): e2805.
[30]
Wang XX, Mao GH, Li QQ, Tang J, Zhang H, Wang KL, et al. Neuroprotection of NAD(+) and NBP against ischemia/reperfusion brain injury is associated with restoration of sirtuin-regulated metabolic homeostasis. Front Pharmacol 2023; 14: 1096533.
[31]
Zhang W, Xu L, Yu Z, Zhang M, Liu J, Zhou J. Inhibition of the glycolysis prevents the cerebral infarction progression through decreasing the lactylation levels of LCP1. Mol Biotechnol 2023; 65(8): 1336-45.
[32]
Thoni V, Mauracher D, Ramalingam A, Fiechtner B, Sandbichler AM, Egg M. Quantum based effects of therapeutic nuclear magnetic resonance persistently reduce glycolysis. iScience 2022; 25(12): 105536.
[33]
Chen L, Xu M, Huang Q, Wen C, Ren W. Lactate dehydrogenase predicts hemorrhagic transformation in patients with acute ischemic stroke. Gerontology 2023; 69(5): 571-80.
[34]
Jin XX, Fang MD, Hu LL, Yuan Y, Xu JF, Lu GG, et al. Elevated lactate dehydrogenase predicts poor prognosis of acute ischemic stroke. PLoS One 2022; 17(10): e0275651.